CNRGH
Potaczek DP. et al.
Epigenetics and allergy: from basic mechanisms to clinical applications.
Epigenomics (2017) Apr. 9(4):539-571.
doi: 10.2217/epi-2016-0162
Schartner V. et al.
Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy.
Acta Neuropathol. (2017) Apr. 133(4):517-533.
doi: 10.1007/s00401-016-1656-8
Suchon P. et al.
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.
Sci Rep. (2017) Apr. 7:45507.
doi: 10.1038/srep45507
Tost J. et al.
Epigenetics of the immune system and alterations in inflammation and autoimmunity Foreword.
Epigenomics (2017) Apr. 9(4):371-373.
doi: 10.2217/epi-2017-0026
Mobuchon L. et al.
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.
NPJ Genom Med. (2017) Mar. 2. pii: 5.
doi: 10.1038/s41525-017-0008-5
Bohm J. et al.
ORAI1 mutations with distinct channel gating defects in tubular aggregate myopathy.
Human Mutation (2017).Mar. 38 (4): 426-438
doi: 10.1002/humu.23172
Arseneault M. et al.
Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
Sci Rep. (2017) Mar. 7:44876.
doi: 10.1038/srep44876
Lornage X. et al.
Recessive MYPN mutations cause cap myopathy with occasional nemaline rods.
Ann Neurol. 2017 Mar. 81(3):467-473.
doi: 10.1002/ana.24900
Arandel L. et al.
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Disease Models Mechanisms (2017) Feb. 10: 487-497.
doi: 10.1242/dmm.027367
Bougneres P. et al.
Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis.
PLoS One (2017) Feb 2. 12(2):e0170658.
doi: 10.1371/journal.pone.0170658